A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pert... Dahkki Marlow, R, Kuriyakose, S, Mesaros, N, Han, HH, Tomlinson, R, Faust, SN, Snape, MD, Pollard, AJ, Finn, A

Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study. Dahkki Khatami, A, Snape, MD, Wysocki, J, John, T, Westcar, S, Mesaros, N, Peddiraju, K, Boutriau, D, Yu, L, Pollard, A

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial. Dahkki Khatami, A, Snape, MD, John, T, Westcar, S, Klinger, C, Rollinson, L, Boutriau, D, Mesaros, N, Wysocki, J, Galaj, A, Yu, L, Pollard, A